Dexmedetomidine controls agitation and facilitates reliable, serial neurological examinations in a non-intubated patient with traumatic brain injury

Neurocritical Care

Volumn 15, Issue 1, 2011, Pages 175-181

  Tang, Julin F ^a   Chen, Po Liang ^a   Tang, Eric J ^a   May, Todd A ^b   Stiver, Shirley I ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Agitation; Alcohol withdrawal; Dexmedetomidine; Hypercarbia; Hypoxemia; Traumatic brain injury

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; FOLIC ACID; LORAZEPAM; OXYGEN; PHENYTOIN; PROPRANOLOL; SODIUM CHLORIDE; THIAMINE;

AGED; AGITATION; ALCOHOL ABUSE; ALCOHOL WITHDRAWAL; ANAMNESIS; ARTICLE; ATELECTASIS; CASE REPORT; CEREBRAL SALT WASTING; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DISEASE SEVERITY; DRUG DOSE TITRATION; FALLING; GLASGOW COMA SCALE; HEART ATRIUM FIBRILLATION; HEART RATE; HOSPITALIZATION; HUMAN; HYPONATREMIA; INTENSIVE CARE UNIT; MALE; NEUROLOGIC EXAMINATION; OXYGEN SATURATION; PRIORITY JOURNAL; PULSE OXIMETRY; SEIZURE; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; THORAX RADIOGRAPHY; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; TREATMENT RESPONSE; UNCONSCIOUSNESS;

AGED; ALCOHOLISM; BRAIN INJURIES; DEXMEDETOMIDINE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; NEUROLOGIC EXAMINATION; PSYCHOMOTOR AGITATION;

EID: 80051621714     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-009-9315-8     Document Type: Article

References (31)

1. Helmy A, Vizcaychipi M, Gupta AK. Traumatic brain injury: Intensive care management. Br J Anaesth. 2007;99:32-42. (Pubitemid 47078665)
2. Yost DA. Alcohol withdrawal syndrome. Am Fam Physician. 1996;54:657-64, 69.
3. Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma. 1993;34:216-22. (Pubitemid 23111023)
4. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125-33. (Pubitemid 23001123)
5. Coursin DB, Maccioli GA. Dexmedetomidine. Curr Opin Crit Care. 2001;7:221-6. (Pubitemid 32868470)
6. Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA. 1997;278:144-51.
7. DeCarolis DD, Rice KL, Ho L, Willenbring ML, Cassaro S. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit. Pharmacotherapy. 2007;27:510-8. (Pubitemid 46536231)
8. Pletcher MJ, Fernandez A, May TA, et al. Unintended consequences of a quality improvement program designed to improve treatment of alcohol withdrawal in hospitalized patients. Jt Comm J Qual Patient Saf. 2005;31:148-57.
9. Hecksel KA, Bostwick JM, Jaeger TM, Cha SS. Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital. Mayo Clin Proc. 2008;83:274-9. (Pubitemid 351469236)
10. Al-Sanouri I, Dikin M, Soubani AO. Critical care aspects of alcohol abuse. South Med J. 2005;98:372-81. (Pubitemid 40381717)
11. Mayo-Smith MF, Beecher LH, Fischer TL, et al. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med. 2004;164:1405-12. (Pubitemid 38937851)
12. Riihioja P, Jaatinen P, Haapalinna A, Kiianmaa K, Hervonen A. Effects of dexmedetomidine on rat locus coeruleus and ethanol withdrawal symptoms during intermittent ethanol exposure. Alcohol Clin Exp Res. 1999;23:432-8. (Pubitemid 29144836)
13. Darrouj J, Puri N, Prince E, Lomonaco A, Spevetz A, Gerber DR. Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal. Ann Pharmacother. 2008;42: 1703-5.
14. Maccioli GA. Dexmedetomidine to facilitate drug withdrawal. Anesthesiology. 2003;98:575-7. (Pubitemid 36592828)
15. Riihioja P, Jaatinen P, Oksanen H, Haapalinna A, Heinonen E, Hervonen A. Dexmedetomidine alleviates ethanol withdrawal symptoms in the rat. Alcohol. 1997;14:537-44. (Pubitemid 27500588)
16. Rovasalo A, Tohmo H, Aantaa R, Kettunen E, Palojoki R. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: A case report. Gen Hosp Psychiatry. 2006; 28:362-3. (Pubitemid 43929129)
17. Meagher DJ. Delirium: Optimising management. BMJ. 2001;322: 144-9. (Pubitemid 32116194)
18. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382-94. (Pubitemid 30620311)
19. Lonergan E, Luxenberg J, Areosa Sastre A, Wyller TB. Benzodiazepines for delirium. Cochrane Database Syst Rev. 2009; CD006379.
20. Bekker A, Sturaitis MK. Dexmedetomidine for neurological surgery. Neurosurgery. 2005;57:1-10 (discussion 1).
21. Aryan HE, Box KW, Ibrahim D, Desiraju U, Ames CP. Safety and efficacy of dexmedetomidine in neurosurgical patients. Brain Inj. 2006;20:791-8. (Pubitemid 44594159)
22. Werner C. Effects of analgesia and sedation on cerebrovascular circulation, cerebral blood volume, cerebral metabolism and intracranial pressure. Anaesthesist. 1995;44(Suppl 3):S566-72. (Pubitemid 26020613)
23. Zornow MH, Scheller MS, Sheehan PB, Strnat MA, Matsumoto M. Intracranial pressure effects of dexmedetomidine in rabbits. Anesth Analg. 1992;75:232-7.
24. Cosar M, Eser O, Fidan H, et al. The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage. Surg Neurol. 2009;71:54-9 (discussion 9).
25. Ma D, Hossain M, Rajakumaraswamy N, et al. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol. 2004;502:87-97. (Pubitemid 39311368)
26. Drummond JC, Dao AV, Roth DM, et al. Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology. 2008;108:225-32. (Pubitemid 351156732)
27. Karlsson BR, Forsman M, Roald OK, Heier MS, Steen PA. Effect of dexmedetomidine, a selective and potent alpha 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg. 1990;71:125-9.
28. Nakano T, Okamoto H. Dexmedetomidine-induced cerebral hypoperfusion exacerbates ischemic brain injury in rats. J Anesth. 2009;23:378-84.
29. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients-a randomized trial. JAMA. 2009;301(5):489-99.
30. Riihioja P, Jaatinen P, Oksanen H, Haapalinna A, Heinonen E, Hervonen A. Dexmedetomidine, diazepam, and propranolol in the treatment of ethanol withdrawal symptoms in the rat. Alcohol Clin Exp Res. 1997;21:804-8. (Pubitemid 27355677)
31. Devlin JW. The pharmacology of oversedation in mechanically ventilated adults. Curr Opin Crit Care. 2008;14:403-7.